USA flag logo/image

An Official Website of the United States Government

Ligo-miR - A Multiplexed Single Molecule Ligation Assay for miRNA Profiling

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R43GM103360
Solicitation Year:
2012
Solicitation Topic Code:
NIGMS
Solicitation Number:
PA10-122
Small Business Information
CIRCULOMICS, INC.
810 Wyman Park Drive Unit G01 BALTIMORE, MD -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: Ligo-miR - A Multiplexed Single Molecule Ligation Assay for miRNA Profiling
Agency: HHS
Contract: 1R43GM103360-01A1
Award Amount: $399,684.00
 

Abstract:

DESCRIPTION (provided by applicant): Ligo-miR - A Multiplexed Single Molecule Ligation Assay for miRNA profiling MicroRNAs (miRNA) are short, noncoding RNAs with pervasive roles throughout gene expression in cellular processes such as differentiation and disease states such as cancer. Uncovering the roles of these molecules in development and tumorigenesis are key steps to the discovery of robust, new biomarkers and potential disease cures. The ability to profile miRNA expression at single cell resolution across a tumor mass could lead to targeted therapies that are effective at eliminating rather than merely shrinking tumors. No existing miRNA analysis method combines high sensitivity with true multiplexing and small volume capability. In this Phase I SHIFTproposal, a PCR-free, multiplex ligation assay for miRNA profiling called Ligo-miR will be developed. Hybridization and ligation of locked nucleic acid probes will be used to generate miRNA specific ligation products encoded by length. The ligation products will then be directly identified and quantified using microfluidic single molecul free solution hydrodynamic separation (SML-FSHS). The ligation mechanism will enable Ligo-miR to perform multiplex detection of up to 20 miRNA per reaction while the single molecule analysis platform will enable PCR-free detection with a sensitivity of lt 20 copies and sample volume lt 10 pL. This unique combination of high sensitivity and near-zero sample volume will form the foundation for a Phase II single cell miRNA profiling platform. Furthermore, this architecture can be easily scaled to even higher degrees of multiplexing (gt50-plex) and throughput through microfluidics. In Aim 1, we will develop the fundamental Ligo-miR assay using synthetic RNA targets to mimic 3 classical miRNAs, let-7a, miR-16, and miR-21. In Aim 2, we will design a SML-FSHS microfluidic device to analyze the ligation products generated in Aim 1. In Aim 3, we will integrate these techniques into a multiplexed assay that can detect 20 miRNAs per reaction. Finally, in Aim 4, we will use the 20-plex assay to profile miRNA in 3 human cancer cell lines and 3 normal tissues. The Ligo-miR results will then be compared to published microarray and RT-PCR data. Such a method not only has applications in miRNAtumor profiling but also in other applications with rare samples such as clinical diagnostics using circulating tumor cells and cell-free miRNA. PUBLIC HEALTH RELEVANCE: Ligo-miR - A Multiplexed Single Molecule Ligation Assay for miRNA profilingMicroRNAs have been recently found to play key roles throughout the regulation of gene expression. Thus, the development of a sensitive, new assay platform for microRNA analysis will lead to better understanding of tumor development and cancer progression. In turn, this could lead more specific and robust cancer biomarkers and more effective, targeted cancer therapies.

Principal Investigator:

Kelvin Liu
626-202-4825
circulomics@gmail.com

Business Contact:

Kelvin J. Liu
626-202-4825
circulomics@gmail.com
Small Business Information at Submission:

CIRCULOMICS, INC.
810 Wyman Park Drive Unit G01 BALTIMORE, MD -

EIN/Tax ID: 126471468
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No